๐Ÿ”ฌDeep Research

ACHV โ€” Achieve Life Sciences Inc ยท catalysts, narrative & risks

ยท20 sourcesACHV forecast โ†’

Achieve Life Sciences Inc. (Nasdaq: ACHV) โ€” Point-in-Time Overview (as of 2026-10-03)

Company Profile

Achieve Life Sciences is a late-stage specialty pharmaceutical company developing cytisinicline, a plant-based alkaloid for nicotine dependence treatment (smoking and e-cigarette cessation) [2]. The company is pre-revenue with no marketed product, and is a $685 million-market-cap biotech [6], [7].

Recent Catalysts (Last ~1โ€“3 Months)


AI-assisted research from the K3vl4r desk โ€” not personalized investment advice. More research โ†’